Vj. Venema et al., BRADYKININ-STIMULATED PROTEIN-TYROSINE PHOSPHORYLATION PROMOTES ENDOTHELIAL NITRIC-OXIDE SYNTHASE TRANSLOCATION TO THE CYTOSKELETON, Biochemical and biophysical research communications, 226(3), 1996, pp. 703-710
Stimulation of bovine aortic endothelial cells (BAEC) with bradykinin
produces cycles of tyrosine phosphorylation/dephosphorylation of a 90
kDa endothelial nitric oxide synthase (eNOS)-associated protein which
we have termed ENAP-1 (for endothelial nitric oxide synthase-associate
d protein 1). ENAP-1 interacts specifically and tightly with eNOS in B
AEC and is co-immunoprecipitated from cell lysates with anti-eNOS anti
bodies. In addition, anti-phosphotyrosine antibodies co-precipitate eN
OS. Bradykinin-stimulated tyrosine phosphorylation of ENAP-1 is blocke
d by the tyrosine kinase inhibitor, tyrphostin. Dephosphorylation is b
locked by the tyrosine phosphatase inhibitor, orthovanadate. Treatment
of BAEC with bradykinin or the tyrosine phosphatase inhibitor, phenyl
arsine oxide promotes tyrosine phosphorylation of detergent- insoluble
, cytoskeletal proteins accompanied by translocation of eNOS to the cy
toskeletal subcellular compartment. Translocation is blocked by the ty
rosine kinase inhibitor, geldanamycin and does not appear to alter enz
yme catalytic activity. Tyrosine phosphorylation-dependent association
of eNOS with the cytoskeleton may have a role in targeting NO product
ion to specific subcellular locations. (C) 1996 Academic Press, Inc.